In colon cancer, Montal et al. demonstrated that PCK1 was strongly expressed, and that PCK1 overexpression promoted glucose and glutamine utilization, thereby supporting anabolic metabolism and tumor proliferation [9]. The gene discussed is PCK1; the disease is colonic neoplasm.